Novartis tells SC it has right to patent its cancer drug
New Delhi: The Supreme Court today asked Swiss pharma giant Novartis AG whether it should not sell its anti-cancer drug for Rs 5 each to benefit common man.
A bench of Justices Aftab Alam and Ranajan Prakash Desai posed the query to Novartis AG while hearing its plea seeking affirmation of the exclusivity of its blood cancer drug Glivec and its right to get it patented in India.
"Why don`t you sell it for Rs 5? People find it difficult to buy it," the bench asked senior counsel Goapl Subramanium as he, appearing for the firm, argued that getting the drug patented would not affect the treatment of the poor.
Taking a dig at the huge cost of the drug, the bench remarked in a lighter vein the cost was perhaps prohibitive even for the apex court judges.
"The monthly cost of Rs 1.2 lakh is too high. The government may revoke our reimbursement of medical bill if it goes to that extent," the bench quipped.
The bench observed that public "trust comes not from the pricing but from the efficacy of the drug."
It made the observation as Subramanium asserted that it has the right to patent its blood cancer drug as it was a completely new medicine, while seeking to assure the court that treatment to the poor patients would not be affected because of it.
The firm tried to dispel the impression that its drug would be beyond the reach of the poor cancer patients as the bench said the pricing of the medicine was in its sub-conscious mind as the monthly dosage costs around Rs 1.2 lakh.
"The purpose is not to make money from the poor. This is not the purpose but am I not entitled for patent for our drug? We are fighting the case on principle," said Subramanium.
"We are totally conscious of our social responsibility. Conduct of Novartis is socially responsible and we are fighting for our rights for patent," he said when the bench observed that the cost of the drug is too high.
Subramanium, however, submitted that there should be no cause of concern that the poor would not get treatment and submitted that 85 percent of the patients are treated free under its scheme.
As the apex court commenced its final hearing over the Novartis AG`s plea for getting its blood cancer drug Glivec patented in India, the firm submitted it has done lot of research and spent around 800 million dollar to bring it out.
The firm also refuted allegations of various social organisations that it was just an attempt by Novartis to evergreen its patent right.
Ever-greening of patent right is a strategy allegedly adopted by the innovators having patent rights over products to renew it by bringing in some minor changes such as adding new mixtures or formulations. It is done when their patent is about to expire.
Under it, either they take a new patent or stretch the time permissible under the law.
Earlier, the Indian patent authorities had denied the exclusivity claims of Novartis and later it was also upheld by the appellate board IPAB. Novartis has challenged the order of Chennai-based Intellectual Property Appellate Board (IPAB), which rejected its appeal against patent department`s decision on Glivec.
The Comptroller General of Patent and Design had denied patent to Glivec on several grounds including its alleged failure to meet stipulations under sections 3(d) and 3(b) of the Indian Patent Law.
Section 3(d) restricts patents for already known drugs unless the new claims are superior in terms of efficacy.
Section 3(b) restricts patents for products that are against public interest and do not demonstrate enhanced efficacy over existing products.
In 2003, Novartis had obtained exclusive marketing rights (generic versions of Glivec were stopped from being made) for the drug, based on its patent application.
While the Swiss firm had challenged the patent office`s verdict in the Madras High Court, its appeals were transferred to IPAB, which held in July 2009 that Glivec did not meet the requirement of increased therapeutic efficacy.
More from India
More from World
More from Sports
More from Entertaiment
- PM Modi speaks at Golden Jubilee celebrations of poet Dinkar’s works
- Vadodara: Policemen seen dancing with bar girls
- Coal scam: Naveen Jindal, Madhu Koda and others get bail
- DNA: IAF Mirage 2000 fighter plane lands successfully on Yamuna expressway
- One year of Modi govt: Arun Jaitley addresses press conference
- Zee Media Exclusive: Kangana, Madhavan talk about their film 'Tanu Weds Manu Returns'
- DNA: Osama documents show 'Indian brother in Madinah' financed al Qaeda
- ISIS executes Syrian fighter using anti-tank rocket launcher
- DNA: Harmful chemicals found in Maggi, Nestle India still in denial mode
- Zee Media Exclusive interview with Congress leader Kamal Nath
- CM Kejriwal shortlists 39 'unwanted' IAS officers in Delhi
- Columbia student takes rape-protest mattress to graduation
- Mumbai: One injured in shootout at Film City
- Delhi: Car catches fire after crash, one dead
- DNA: Modi-led NDA govt's hits and misses in one year
- Jayalalithaa makes public appearance, meets Governor: As it happened
- Mumbai firm booked for denying Muslim MBA graduate job on religious grounds, probe ordered
- Geelani's passport application incomplete, cannot be processed: MEA
- IPL 2015, Qualifier 2: CSK vs RCB - As it happened...
- India to soon have its own space shuttle!
- Kejriwal slams notification on LG's powers, says Modi running Delhi govt through back door
- WBBSE 10th Madhyamik Results 2015: West Bengal Board (wbbse.org & wbresults.nic.in) Class 10th Madhyamik Pariksha Results 2015 to be announced on May 22
- Don't know what will happen to my career, says Ranbir Kapoor
- Tanu Weds Manu Returns movie review: Brilliant execution, superb performance!
- Manohar Parrikar meets troops at Siachen base camp
- Wbbse.org 10th Madhyamik Pariksha Results 2015: West Bengal Board (wbresults.nic.in) Class 10th, WB MP Results 2015 to be announced today shortly
- Businessman shot next to Amitabh Bachchan's shooting location in Mumbai Film City
- British tourist masturbated at in Mumbai; Indian men apologise
- West Bengal Board (wbbse.org & wbresults.nic.in) Class 10th Madhyamik Pariksha (MP) Results 2015 to be announced today at 10 AM
- After land bill, net neutrality, Rahul Gandhi to fight for ex-servicemen now